首页> Cancers> Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.

Value of Early Circulating Tumor Cells Dynamics to Estimate Docetaxel Benefit in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients.

导出 OA

翻译打印收藏纠错

第一作者： Rebeca,Lozano

第一单位： Genitourinary Cancer Traslational Research Group, The Institute of Biomedical Research in Málaga (IBIMA), 29010 Málaga, Spain.;Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain.

作者： Rebeca,Lozano ^[1] ; David,Lorente ^[2] ; Isabel M,Aragon ^[1] ; Nuria,Romero-Laorden ^[3] ; Paz,Nombela ^[4] ; Joaquim,Mateo ^[5] ; Alison H M,Reid ^[6] ; Ylenia,Cendón ^[4] ; Diletta,Bianchini ^[6] ; Casilda,Llacer ^[7] ; Shahneen K,Sandhu ^[8] ; Adam,Sharp ^[6] ; Pasquale,Rescigno ^[9] ; Teresa,Garcés ^[1] ; Maria I,Pacheco ^[1] ; Penelope,Flohr ^[10] ; Christophe,Massard ^[11] ; Pedro P,López-Casas ^[4] ; Elena,Castro ^[1] ; Johann S,de Bono ^[6] ; David,Olmos ^[1]

作者单位： Genitourinary Cancer Traslational Research Group, The Institute of Biomedical Research in Málaga (IBIMA), 29010 Málaga, Spain.;Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain. ^[1] Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain.;Servicio de Oncología Médica, Hospital Provincial de Castellón, 12004 Castellón de la Plana, Spain. ^[2] Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain.;Hospital Universitario La Princesa, 28006 Madrid, Spain. ^[3] Spanish National Cancer Research Centre (CNIO), Prostate Cancer Clinical Research Unit, 28029 Madrid, Spain. ^[4] The Institute of Cancer Research, London SW7 3RP, UK.;The Royal Marsden NHS Foundation Trust, Sutton, London SM2 5PT, UK.;Vall d'Hebron Institute of Oncology (VHIO), 08035 Barcelona, Spain. ^[5] The Institute of Cancer Research, London SW7 3RP, UK.;The Royal Marsden NHS Foundation Trust, Sutton, London SM2 5PT, UK. ^[6] Genitourinary Cancer Traslational Research Group, The Institute of Biomedical Research in Málaga (IBIMA), 29010 Málaga, Spain.;The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia. ^[7] The Institute of Cancer Research, London SW7 3RP, UK.;The Royal Marsden NHS Foundation Trust, Sutton, London SM2 5PT, UK.;The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC 3000, Australia. ^[8] The Institute of Cancer Research, London SW7 3RP, UK.;The Royal Marsden NHS Foundation Trust, Sutton, London SM2 5PT, UK.;Candiolo Cancer Institute, FPO-IRCCS, 10060 Turin, Italy. ^[9] The Institute of Cancer Research, London SW7 3RP, UK. ^[10] The Institute of Cancer Research, London SW7 3RP, UK.;Department of Medical Oncology, Faculté de Medicine Paris-Sud XI, Institut Gustave Roussy, 94805 Villejuif, France. ^[11]

关键词 PSA biomarkers circulating tumor cells docetaxel metastatic castration-resistant prostate cancer

DOI 10.3390/cancers13102334

PMID 34066080

发布时间 2021-06-05

基金项目